Literature DB >> 8471324

Incidence of second primary cancer following testicular cancer.

H Møller1, A Mellemgaard, G K Jacobsen, D Pedersen, H H Storm.   

Abstract

The incidence of second primary cancers was investigated in 6187 Danish men diagnosed with testicular cancer in the period 1943-1987. During the course of 59,000 person years, 459 subsequent primary cancers occurred. The relative risks were significantly increased for leukaemia, gastric cancer, pancreatic cancer, bladder cancer, non-melanoma skin cancer and kidney cancer. Increased incidence was furthermore suggested for cancer of the rectum, prostate and lung. The increased incidence of leukaemia appeared in the first 10 years after testicular cancer diagnosis. The excess incidence for gastric cancer, pancreatic cancer, rectal cancer and lung cancer was strongest 10-19 years after testicular cancer, while the relative risk of non-melanoma skin cancer and prostate cancer increased throughout the period of follow-up. The increased incidence of cancer in this cohort is most likely an effect of radiotherapy used for testicular cancer. It is proposed that the different incidence patterns over time after testicular cancer diagnosis reflect differences in the growth rate of tumours originating in different tissues.

Entities:  

Mesh:

Year:  1993        PMID: 8471324     DOI: 10.1016/s0959-8049(05)80344-2

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  8 in total

Review 1.  Comparative tolerability of chemotherapy regimens for germ cell cancer.

Authors:  S Culine; J P Droz
Journal:  Drug Saf       Date:  2000-05       Impact factor: 5.606

2.  Retroperitoneal lymph node dissection for high-risk stage I and stage IIA seminoma.

Authors:  Zaza Mezvrishvili; Laurent Managadze
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

Review 3.  Renal cell carcinoma following testicular cancer: case report and literature review.

Authors:  Nathan Lawrentschuk; Dennis Gyomber; Damien M Bolton
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

4.  Adjuvant carboplatin treatment for seminoma clinical stage I.

Authors:  K P Dieckmann; J Krain; J Küster; B Brüggeboes
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

Review 5.  Second cancer after treatment of malignant germ-cell tumors.

Authors:  S D Fosså; E H Wanderås; K Heimdal
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

6.  DNA methyltransferase 3B expression is associated with poor outcome of stage I testicular seminoma.

Authors:  Eri Arai; Tohru Nakagawa; Saori Wakai-Ushijima; Hiroyuki Fujimoto; Yae Kanai
Journal:  Histopathology       Date:  2012-03-06       Impact factor: 5.087

7.  Cryptorchidism and testicular germ cell tumors: comprehensive meta-analysis reveals that association between these conditions diminished over time and is modified by clinical characteristics.

Authors:  Kimberly Banks; Ellenie Tuazon; Kiros Berhane; Chester J Koh; Roger E De Filippo; Andy Chang; Steve S Kim; Siamak Daneshmand; Carol Davis-Dao; Juan P Lewinger; Leslie Bernstein; Victoria K Cortessis
Journal:  Front Endocrinol (Lausanne)       Date:  2013-02-18       Impact factor: 5.555

8.  Risk of cancer in relatives of testicular cancer patients.

Authors:  K Heimdal; H Olsson; S Tretli; P Flodgren; A L Børresen; S D Fossa
Journal:  Br J Cancer       Date:  1996-04       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.